Japan vs Netherlands: Memorandum items, Financial derivatives (net marked to market)

Japan
959.00 million
in 2025
Netherlands
283.00 million
in 2025
Japan rank
4th
Netherlands rank
6th

Memorandum items, Financial derivatives (net marked to market) over time

  • Japan
  • Netherlands
-2.0B02.0B4.0B6.0B200020122025

How they compare

Japan currently reports 959.00 million against 283.00 million in Netherlands, a difference of 676.00 million.

That makes Japan's figure about 3.4 times Netherlands's.

The two have swapped places 8 times across 15 shared years of data; in 2011 it was Japan ahead.

Japan ranks 4th and Netherlands ranks 6th of 53 countries.

Japan has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Japan Netherlands Difference Ahead
2010s 1.37 billion -90.11 million 1.46 billion Japan
2020s 200.83 million -20.50 million 221.33 million Japan

Averages of every year both report within each decade.

Frequently asked questions

Which has higher memorandum items, financial derivatives (net marked to market), Japan or Netherlands?
Japan, at 959.00 million against 283.00 million in Netherlands as of 2025.
What is the difference in memorandum items, financial derivatives (net marked to market) between Japan and Netherlands?
676.00 million, with Japan ahead.
How many years of comparable data are there for Japan and Netherlands?
15 years are reported by both, from 2011 to 2025.
How do Japan and Netherlands rank globally for memorandum items, financial derivatives (net marked to market)?
Japan ranks 4th and Netherlands ranks 6th of 53 countries.
Where does this data come from?
International Monetary Fund, published as Memorandum items, Financial derivatives (net marked to market), swaps, Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Japan vs Netherlands: Memorandum items, Financial derivatives (net marked to market). Statizoid, drawing on International Monetary Fund. Retrieved 13 September 2026, from https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-swaps-assets-international/japan/netherlands/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under IMF Terms and Conditions (attribution required); please keep the attribution.

<a href="https://financial-sector.statizoid.com/compare/memorandum-items-financial-derivatives-net-marked-to-market-swaps-assets-international/japan/netherlands/">Japan vs Netherlands: Memorandum items, Financial derivatives (net marked to market)</a> — Statizoid

About this data

Indicator
Memorandum items, Financial derivatives (net marked to market), swaps, Assets (International Reserves and Foreign Currency Liquidity: Guidelines for a Data Template 2013 (IRFCL 2013), Monetary Authorities and Central Government excluding Social Security)
Source
International Monetary Fund
Licence
IMF Terms and Conditions (attribution required)
Coverage
55 places, 1,034 data points, 1999–2025
Last refreshed

The International Reserves and Foreign Currency Liquidity (IRFCL, or the “Reserves Data Template”) dataset includes data on the amount and composition of countries’ official reserve assets, other foreign currency assets held by monetary authorities and central governments, and short-term foreign currency obligations and related activities of monetary authorities and central governments that can lead to drains on official reserves and other foreign currency assets. This website re-disseminates IMF member countries' data on international reserves and foreign currency liquidity in a common template and in a common currency (the U.S. dollar). Historical data by country are also available. Please note that the re-dissemination of the template data by the Fund does not constitute endorsement of the quality of the data by the Fund.